Amendment: SEC Form SC 13G/A filed by Altimmune Inc.
$ALT
Biotechnology: Pharmaceutical Preparations
Health Care
Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
2/28/2025 | Mkt Perform | William Blair | |
1/8/2025 | $18.00 | Buy | Stifel |
11/12/2024 | $26.00 | Buy | UBS |
4/29/2024 | Buy → Neutral | Guggenheim | |
1/24/2024 | $13.00 | Neutral | Goldman |
3/22/2023 | $20.00 → $6.00 | Buy → Neutral | Goldman |
12/1/2022 | $20.00 | Buy | Goldman |
12/29/2021 | $30.00 | Buy | Jefferies |